Cyclin-dependent kinase 4/6 inhibitors in the continuum of care for hormone receptor-positive and human epidermal growth factor receptor-2 negative

Introduction

CDK4/6 inhibitors in the continuum of care for HR+ HER2- Breast Cancer

Objectives

1. Recent updates about CDK4/6 inhibitors in the adjuvant setting
2. Strategies for side effect management and improving patient adherence when using CDK 4/6 inhibitors

This Course For :

Physician ( Internal Medicine , Oncology , General practitioner )
Resident / Fellow ( Internal Medicine , Oncology , General practitioner )

Speaker

Price

Course Fee

FREE

FREE
See Registration Policies, Cancellations & Refunds

Contact Information

Organization : Virtual Medical Academy
Phone : 920008161
Email : [email protected]

  • 22 May 2024    To    22 May 2024
  • 07:30 PM  To  09:00 PM
  • Certificate Available
  • SCFHS 2 CME hours
  • Online
  Add to Calendar 05/22/2024 07:30 PM 05/22/2024 09:00 PM Asia/ Riyadh Cyclin-dependent kinase 4/6 inhibitors in the continuum of care for hormone receptor-positive and human epidermal growth factor receptor-2 negative Cyclin-dependent kinase 4/6 inhibitors in the continuum of care for hormone receptor-positive and human epidermal growth factor receptor-2 negative https://medicalacademy.org/portal/event/view/2093
Cyclin-dependent kinase 4/6 inhibitors in the continuum of care for hormone receptor-positive and human epidermal growth factor receptor-2 negative